Regulatory Advocacy

The AAO-HNS has a long history of working closely with regulatory agencies (e.g., Centers for Medicare & Medicaid Services, U.S. Food and Drug Administration) to maintain our visibility and credibility with national representatives regarding federal regulatory issues.

We believe that advocacy is the key to defining the future of otolaryngology. Federal regulatory advocacy is a top priority of the AAO-HNS.

Academy Comments on 2016 Medicare Physician Fee Schedule
The Academy submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the 2016 Medicare Physician Fee Schedule final rule. The comments address several specific payment policy issues affecting otolaryngology including: practice expense changes; Global Surgical Package valuation; Physician Quality Reporting System and Qualified Clinical Data Registry requirements; Physician Compare; and Value Based Payment Modifier program.

Read the comments.

Academy Submits Comments on Stage 3 and Modifications to EHR Meaningful Use Final Rule
On December 7, the Academy submitted comments on the CMS final rule regarding Stage 3 and Modifications to the EHR Meaningful Use program. Academy comments focus on the need for increased flexibility, interoperability, continuation of 90-day reporting periods, and measure thresholds and requirements.

Read the comments.

Academy Comments on 2016 HOPPS Rule
The Academy submitted comments on the final rule for CY 2016 Hospital Outpatient Prospective Payment System (HOPPS) and Ambulatory Surgical Center (ASC) Payment Rate. The Academy addressed: point-of-care imaging access for patients and changes to Ambulatory Payment Classifications assignments. Read the letter.

Read the comments.

Academy Releases Summary of 2016 Medicare Physician Fee Schedule Final Rule
The Academy has summarized key provisions of the 2016 Medicare Physician Fee Schedule final rule that affect otolaryngology including: practice expense changes; Global Surgical Package valuation; Physician Quality Reporting System and Qualified Clinical Data Registry requirements; Physician Compare; and Value Based Payment Modifier program.

Read the summary.

Academy Comments on the MACRA RFI
Using feedback solicited from key Academy leaders, the Academy has submitted comments on the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Request for Information (RFI). The RFI primarily consists of questions concerning the implementation process for the new Merit-Based Incentive Payment System (MIPS) and eligible Alternative Payment Models (APMs). We anticipate that the newly created MIPS program will significantly impact otolaryngologists and will follow this matter closely. 

Read the comments